ANDA 200914, held by Rising. Cytarabine.
As of Nov 16, 2026, ANDA 200914 (Cytarabine), held by Rising, was first approved by FDA on Dec 13, 2011, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 13, 2011 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cytarabine20MG/ML · injectable;injection | Cytarabine | Discontinued |
| Oct 13, 2020 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jan 16, 2015 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jan 16, 2015 | Supplement 4Labeling · Standard review | Approved | None posted |
| Dec 13, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters